相关实验视频
Updated: Jul 5, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.6K
喘中的小呼吸道:从炎症和病理生理学到治疗反应
Anastasia Siora1, Angelos Vontetsianos1, Nikolaos Chynkiamis1
11st Department of Respiratory Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria Chest Hospital, Athens, Greece.
Respiratory medicine
|January 16, 2024
概括
在喘中,小呼吸道功能障碍,通常是无声的,会给诊断带来挑战. 新兴的生物治疗方法对管理小呼吸道炎症和重塑有希望.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 小气道 (直径小于2毫米) 在喘中至关重要,通常在症状出现之前就受到影响,称为"沉默区".
- 评估小呼吸道功能障碍是具有挑战性的,因为它们的大小和位置,阻碍了传统的肺功能测试.
- 目前的诊断方法缺乏明确的黄金标准,需要结合方法来准确评估小气道.
研究的目的:
- 审查挑战和目前的方法,以评估小气道功能障碍在喘.
- 探索现有和新型喘疗法对小呼吸道的影响.
- 突出新兴生物治疗在管理小呼吸道病理方面的潜力.
主要方法:
- 关于喘中小气道评估现有文献的审查.
- 分析肺功能测试 (脉冲振荡计,洗,身体囊造影) 和成像技术.
- 评估常规和生物喘疗法对小呼吸道的影响.
主要成果:
- 小呼吸道功能障碍可以在明显的喘症状和螺旋计变化之前出现.
- 没有一种单一的方法是黄金标准;对于小型气道评估,建议采用联合方法.
- 传统的喘治疗方法会影响小气道的参数.
- 生物疗法在减少小气道炎症和重塑方面显示出潜力.
结论:
- 在喘中有效评估小气道需要采用多模式方法.
- 生物治疗为解决小气道炎症和喘重塑提供了一个有希望的新途径.
- 新型疗法可以通过向"沉默区"来显著改变喘进展和临床结果.
相关概念视频
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445

